<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0016195"><a href="http://purl.obolibrary.org/obo/MONDO_0016195">MONDO:0016195</a></h3>
<p><strong>Label:</strong> qualitative or quantitative defects of beta-myosin heavy chain (MYH7)</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0018889">MONDO:0018889</a> (hyaline body myopathy),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_53698">Orphanet:53698</a>, <a href="http://purl.obolibrary.org/obo/OMIM_255160">OMIM:255160</a>, <a href="http://purl.obolibrary.org/obo/OMIM_608358">OMIM:608358</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0003707">HP:0003707</a> (Calf muscle pseudohypertrophy) and <a href="http://purl.obolibrary.org/obo/HP_0100022">HP:0100022</a> (Abnormality of movement) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003707">HP:0003707</a> (Calf muscle pseudohypertrophy) and <a href="http://purl.obolibrary.org/obo/HP_0040290">HP:0040290</a> (Abnormality of skeletal muscles) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003707">HP:0003707</a> (Calf muscle pseudohypertrophy) and <a href="http://purl.obolibrary.org/obo/HP_0030236">HP:0030236</a> (Abnormality of muscle size) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003707">HP:0003707</a> (Calf muscle pseudohypertrophy) and <a href="http://purl.obolibrary.org/obo/HP_0011842">HP:0011842</a> (Abnormality of skeletal morphology) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003707">HP:0003707</a> (Calf muscle pseudohypertrophy) and <a href="http://purl.obolibrary.org/obo/HP_0009121">HP:0009121</a> (Abnormal axial skeleton morphology) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003707">HP:0003707</a> (Calf muscle pseudohypertrophy) and <a href="http://purl.obolibrary.org/obo/HP_0009055">HP:0009055</a> (Generalized limb muscle atrophy) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003707">HP:0003707</a> (Calf muscle pseudohypertrophy) and <a href="http://purl.obolibrary.org/obo/HP_0004303">HP:0004303</a> (Abnormality of muscle fibers) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003707">HP:0003707</a> (Calf muscle pseudohypertrophy) and <a href="http://purl.obolibrary.org/obo/HP_0003803">HP:0003803</a> (Type 1 muscle fiber predominance) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003704">HP:0003704</a> (Scapuloperoneal weakness) and <a href="http://purl.obolibrary.org/obo/HP_0003707">HP:0003707</a> (Calf muscle pseudohypertrophy) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003700">HP:0003700</a> (Generalized amyotrophy) and <a href="http://purl.obolibrary.org/obo/HP_0003707">HP:0003707</a> (Calf muscle pseudohypertrophy) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003697">HP:0003697</a> (Scapuloperoneal amyotrophy) and <a href="http://purl.obolibrary.org/obo/HP_0003707">HP:0003707</a> (Calf muscle pseudohypertrophy) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003691">HP:0003691</a> (Scapular winging) and <a href="http://purl.obolibrary.org/obo/HP_0003707">HP:0003707</a> (Calf muscle pseudohypertrophy) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003687">HP:0003687</a> (Centrally nucleated skeletal muscle fibers) and <a href="http://purl.obolibrary.org/obo/HP_0003707">HP:0003707</a> (Calf muscle pseudohypertrophy) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003679">HP:0003679</a> (Pace of progression) and <a href="http://purl.obolibrary.org/obo/HP_0003707">HP:0003707</a> (Calf muscle pseudohypertrophy) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003677">HP:0003677</a> (Slow progression) and <a href="http://purl.obolibrary.org/obo/HP_0003707">HP:0003707</a> (Calf muscle pseudohypertrophy) 66.67%</li>
</ul>
</body>
</html>
